Publications and Media


  • June 16, 2023

    JAMA Network

    Racial Disparities in Lung Cancer Screening Among Veterans, 2013 to 2021

  • October 12, 2023

    American Journal of Oncology

    Medicare Coverage of Amyloid PET: Implications for Clinical Practice

  • April 6, 2023

    The New England Journal of Medicine

    Why Diverse Clinical Trial Participation Matters

  • March 4, 2019

    American Association for Cancer Research: Cancer Epidemiology, Biomarkers & Prevention

    Cancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents

  • May 23, 2023

    Nature: Scientific Reports:

    Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F] DCFPyL PET/CT in prostate cancer men.

  • Novermber 10, 2023

    RSNA: Imaging Cancer

    Alternate CMS Payment Structure for Outpatient Services: A Road to Improving Access to Molecular Imaging in Oncologic Care.

  • April 3, 2023

    National Cancer Institute: Eliminate Inequities – National Cancer Plan

    Goal: Disparities in cancer risk factors, incidence, treatment side effects, and mortality are eliminated through equitable access to prevention, screening, treatment, and survivorship care.


  • Prostate Cancer Clinical Trial: ESCAPE Trial

  • Phil Kantoff discussing Prostate Ca treatment for healthy men presenting with metastatic disease

  • Dr. Reed Omary discusses prevalence of Liver Cancer in Hispanic Women

  • Dr. Lauren Groner talks about Lung Cancer Screening

  • UroToday featuring Dr. Philip Koo interviewing Dr. Joseph Osborne on imaging of Prostate Cancer